VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $202 | -10.6% | 7,500 | 0.0% | 0.01% | -40.0% |
Q2 2023 | $226 | -7.0% | 7,500 | 0.0% | 0.01% | -9.1% |
Q1 2023 | $243 | +41.3% | 7,500 | +25.0% | 0.01% | +37.5% |
Q4 2022 | $172 | -99.9% | 6,000 | 0.0% | 0.01% | +60.0% |
Q3 2022 | $145,000 | -11.6% | 6,000 | 0.0% | 0.01% | -16.7% |
Q2 2022 | $164,000 | +113.0% | 6,000 | +200.0% | 0.01% | +100.0% |
Q1 2022 | $77,000 | +20.3% | 2,000 | 0.0% | 0.00% | +50.0% |
Q4 2021 | $64,000 | +120.7% | 2,000 | +100.0% | 0.00% | +100.0% |
Q3 2021 | $29,000 | -14.7% | 1,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $34,000 | -63.8% | 1,000 | -65.5% | 0.00% | -75.0% |
Q1 2021 | $94,000 | -85.8% | 2,900 | -84.2% | 0.00% | -87.5% |
Q4 2020 | $660,000 | +396.2% | 18,300 | +438.2% | 0.03% | +357.1% |
Q3 2020 | $133,000 | – | 3,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |